Diagnostic device Peptest has been used to help researchers investigate a potential link between salivary pepsin levels and tooth erosion.
Restech, our distribution partner in the US, has launched a branded version of our reflux diagnostic saliva test – known as ‘PepsinCheck by Peptest’.
Salivary pepsin could potentially be used as a non-invasive marker of reflux aspiration in children with gastro-oesophageal reflux disease (GORD) – a new study has shown.
We’re delighted to announce that the Peptest laboratories will reopen for testing of saliva samples for pepsin on Monday 25 May. During the coronavirus pandemic we made the decision to temporarily suspend testing due to restrictions on staff movements and concerns...
I have reflux and one of the symptoms is a cough, so how do I tell the difference between this and the cough caused by COVID-19? Our blog looks at the differences.
Testing saliva for the stomach enzyme pepsin can help speed up the management of reflux, a new research study featuring Peptest has concluded
In these difficult times with the Covid-19 (Coronavirus) outbreak, to protect our staff members, the majority of the RD Biomed and Peptest team will be working from home and following all of the government guidelines for the near future. We are temporarily suspending...
The oesophagus is also called the gullet or food pipe and, along with the mouth, stomach and intestines, is part of the gastrointestinal tract.
Proton pump inhibitors (PPIs) are one of the most commonly prescribed medications in the world – here’s our at-a-glance guide to PPIs.
Testing saliva for the stomach enzyme pepsin can help speed up the management of reflux, a new research study has concluded.
Iqoro – a device that helps to strengthens the oesophagus and diaphragm – has been recognised by the NHS healthcare watchdog for relieving symptoms related to hiatus hernia.
Peptest has been identified as a ‘promising’ way to clinically diagnose patients with non-erosive reflux that doesn’t respond to medication in Japan study.